IDEXX Laboratories, Inc.
US ˙ NasdaqGS ˙ US45168D1046

SecurityIDXX / IDEXX Laboratories, Inc.
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership63 shares
Latest Disclosed Value $ 33,789
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 5.97% decrease in ownership of IDXX / IDEXX Laboratories, Inc.

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 63 shares of IDEXX Laboratories, Inc. (US:IDXX) valued at $33,789 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 67 shares of IDEXX Laboratories, Inc.. This represents a change in shares of -5.97% during the quarter. The current value of the position is $35,416 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP IDEXX Laboratories EC US45168D1046 63 -4 -5.97 34 17.86 0.0498
2025-05-27 2025-03-31 NP IDEXX Laboratories EC US45168D1046 67 -2 -2.90 28 0.00 0.0424
2025-02-26 2024-12-31 NP IDEXX Laboratories EC US45168D1046 69 -5 -6.76 29 -24.32 0.0408
2024-11-25 2024-09-30 NP IDEXX Laboratories EC US45168D1046 74 -3 -3.90 37 0.00 0.0516
2024-08-26 2024-06-30 NP IDEXX Laboratories EC US45168D1046 77 -2 -2.53 38 -11.90 0.0537
2024-05-28 2024-03-31 NP IDEXX Laboratories EC US45168D1046 79 -4 -4.82 43 -8.70 0.0611
2024-02-28 2023-12-31 NP IDEXX Laboratories EC US45168D1046 83 -2 -2.35 46 24.32 0.0691
2023-11-22 2023-09-30 NP IDEXX Laboratories EC US45168D1046 85 -10 -10.53 37 -21.28 0.0598
2023-08-28 2023-06-30 NP IDEXX Laboratories EC US45168D1046 95 1 1.06 48 0.00 0.0720
2023-05-25 2023-03-31 NP IDEXX Laboratories EC US45168D1046 94 -2 -2.08 47 20.51 0.0729
2023-02-24 2022-12-31 NP IDEXX Laboratories EC US45168D1046 96 -2 -2.04 39 25.81 0.0626
2022-11-29 2022-09-30 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 98 -4 -3.92 32 -11.43 0.0521
2022-08-29 2022-06-30 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 102 -2 -1.92 36 -37.50 0.0545
2022-05-31 2022-03-31 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 104 -3 -2.80 57 -20.00 0.0745
2022-02-28 2021-12-31 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 107 -5 -4.46 70 1.45 0.0848
2021-11-24 2021-09-30 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 112 -5 -4.27 70 -5.48 0.0866
2021-08-27 2021-06-30 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 117 -6 -4.88 74 21.67 0.0901
2021-06-01 2021-03-31 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 123 -7 -5.38 60 -6.25 0.0759
2021-03-01 2020-12-31 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 130 -8 -5.80 65 18.52 0.0824
2020-11-25 2020-09-30 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 138 -5 -3.50 54 14.89 0.0728
2020-08-28 2020-06-30 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 143 6 4.38 47 42.42 0.0663
2020-05-28 2020-03-31 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 137 -4 -2.84 33 -8.33 0.0519
2020-02-28 2019-12-31 NP IDEXX LABORATORIES INC USD.1 EC 45168D104 141 -9 -6.00 37 -10.00 0.0510
2019-11-26 2019-09-30 NP IDEXX LABORATORIES INC USD.1 EC US45168D1046 150 150 41 0.0565
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.